Chungnam National University
Also known as: Chungnam National University | Chungnam National University Hospital | Chung-Nam National University Hospital | CHUNGNAM NATIONAL UNIVERSITY HOSPITAL Clinical Research Center | Chungnam national university hospital, Clinical trial center | Chung Nam National University Hospital, clinical vice professor | Chungnam National University Hospital, Daejeon, Korea, Republic of | Chungnam National University Hospital, Department of Neurology | Chungnam National University School of Medicine | Chungnam National Unviersity Hospital of Korea | Chungnam Univ. | Chungnam University Hospital | Clinical Trial Center, Chungnam National University Hospital
Highest phase reached
Phase 4
First clinical trial
May 1, 2004Last known activity
Nov 30, 2025
Timeline
1950s
- Jun 1, 1952
Chungnam National University— Founded
Drugs by trial phase (92 distinct, 71 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (21 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Adenocarcinoma of Lung
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Ascites
- Atrial Fibrillation
- Biliary Tract Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Cholera
- Coronary Artery Disease
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Dyssomnias
- Eczema
- Edema
- Epilepsy
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Foot Ulcer
- Gastritis
- Head and Neck Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Hypocalcemia
- Hyponatremia
- Infarction
- Influenza, Human
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Macular Edema
- Myocardial Infarction
- Myocardial Reperfusion Injury
- Osteoarthritis
- Osteoarthritis, Knee
- Osteosarcoma
- Parasomnias
- Parkinson Disease
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency
- Reperfusion Injury
- Sleep Wake Disorders
- Spondylitis
- Spondylitis, Ankylosing
- ST Elevation Myocardial Infarction
- Ulcer
- Ventricular Remodeling
Recent trials (50)
- NCT07247240CollaboratorPhase 4Nov 30, 2025
- NCT06622603CollaboratorPhase 4Oct 15, 2024
- NCT06330038CollaboratorPhase 4May 1, 2024
- NCT06436976Lead sponsorPhase 2Mar 1, 2024
- NCT06436976Sponsor investigatorPhase 2Mar 1, 2024
- NCT06071143Overall official - principal investigatorPhase 1Nov 30, 2023
- NCT05179889Overall official - principal investigatorPhase 2/Phase 3Jul 6, 2021
- NCT05179889Lead sponsorPhase 2/Phase 3Jul 6, 2021
- NCT05179889Reponsible party - principal investigatorPhase 2/Phase 3Jul 6, 2021
- NCT04952506Overall official - principal investigatorPhase 1Jun 30, 2021
- NCT04627207Overall official - principal investigatorPhase 1Nov 30, 2020
- NCT05351840OfficialPhase 1Nov 2, 2020
- NCT04972539Overall official - principal investigatorPhase 1Aug 1, 2020
- NCT05624853Overall official - principal investigatorPhase 4May 12, 2020
- NCT05051332Overall official - principal investigatorPhase 3Mar 19, 2020
Details
- Founded
- Yuseong, KR Jun 1, 1952
- Last known activity
- Nov 30, 2025